R. Donaldson

First name
R.
Last name
Donaldson
Riley, M., Lambrelli, D., Graham, S., Henry, O., Sutherland, A., Schmidt, A., et al. (2022). Facilitating safety evaluation in maternal immunization trials: a retrospective cohort study to assess pregnancy outcomes and events of interest in low-risk pregnancies in England. Bmc Pregnancy Childbirth, 22, 461. http://doi.org/10.1186/s12884-022-04769-x
Cid-Ruzafa, J., Lacy, B. E., Schultze, A., Duong, M., Lu, Y., Raluy-Callado, M., et al. (2022). Linaclotide utilization and potential for off-label use and misuse in three European countries. Therap Adv Gastroenterol, 15, 17562848221100946. http://doi.org/10.1177/17562848221100946
Nordstrom, B. L., Collins, J. M., Donaldson, R., Engelman, W. A., Tockhorn, A., Zhu, Y., & Zhao, Z. (2015). Treatment patterns and lipid levels among patients with high-risk atherosclerotic CVD in the UK. The British Journal of Cardiology. http://doi.org/10.5837/bjc.2015.034
Ilo, D., Raluy-Callado, M., Graham-Clarke, P., Sadasivan, R., Birt, J., Donaldson, R., et al. (2015). Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study. Int J Clin Pract. http://doi.org/10.1111/ijcp.12657
Ruzafa, C., Paczkowski, R., Boye, K. S., Di Tanna, G. L., Sheetz, M. J., Donaldson, R., et al. (2015). Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study. Int J Clin Pract. http://doi.org/10.1111/ijcp.12640
Lambrelli, D., Merinopoulou, E., Donaldson, R., Mardekian, J., Hlavacek, P., Tarasenko, L., et al. (2017). Real-world treatment patterns among patients initiating on statins in England. Value in Health.
Ramagopalan, S. V., Graham, S., Carroll, R., Raluy-Callado, M., Nordstrom, B. L., Donaldson, R., et al. (2019). Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin. J Comp Eff Res. http://doi.org/10.2217/cer-2019-0005